These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 15895711

  • 1. Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases.
    Aerts JM, Hollak CE, van Breemen M, Maas M, Groener JE, Boot RG.
    Acta Paediatr Suppl; 2005 Mar; 94(447):43-6; discussion 37-8. PubMed ID: 15895711
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The biology of the Gaucher cell: the cradle of human chitinases.
    Bussink AP, van Eijk M, Renkema GH, Aerts JM, Boot RG.
    Int Rev Cytol; 2006 Mar; 252():71-128. PubMed ID: 16984816
    [Abstract] [Full Text] [Related]

  • 5. CCL18: a urinary marker of Gaucher cell burden in Gaucher patients.
    Boot RG, Verhoek M, Langeveld M, Renkema GH, Hollak CE, Weening JJ, Donker-Koopman WE, Groener JE, Aerts JM.
    J Inherit Metab Dis; 2006 Aug; 29(4):564-71. PubMed ID: 16736095
    [Abstract] [Full Text] [Related]

  • 6. Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data.
    Raskovalova T, Deegan PB, Yang R, Pavlova E, Stirnemann J, Labarère J, Zimran A, Mistry PK, Berger M.
    Syst Rev; 2017 Apr 20; 6(1):87. PubMed ID: 28427477
    [Abstract] [Full Text] [Related]

  • 7. Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease.
    Brinkman J, Wijburg FA, Hollak CE, Groener JE, Verhoek M, Scheij S, Aten J, Boot RG, Aerts JM.
    J Inherit Metab Dis; 2005 Apr 20; 28(1):13-20. PubMed ID: 15702402
    [Abstract] [Full Text] [Related]

  • 8. Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease.
    Aerts JM, van Breemen MJ, Bussink AP, Ghauharali K, Sprenger R, Boot RG, Groener JE, Hollak CE, Maas M, Smit S, Hoefsloot HC, Smilde AK, Vissers JP, de Jong S, Speijer D, de Koster CG.
    Acta Paediatr; 2008 Apr 20; 97(457):7-14. PubMed ID: 18339181
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Plasma chitotriosidase activity in Argentinian patients with Gaucher disease, various lysosomal diseases and other inherited metabolic disorders].
    Dodelson de Kremer R, Paschini de Capra A, Angaroni CJ, Giner de Ayala A.
    Medicina (B Aires); 1997 Apr 20; 57(6):677-84. PubMed ID: 9674188
    [Abstract] [Full Text] [Related]

  • 11. Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention.
    Boot RG, Verhoek M, de Fost M, Hollak CE, Maas M, Bleijlevens B, van Breemen MJ, van Meurs M, Boven LA, Laman JD, Moran MT, Cox TM, Aerts JM.
    Blood; 2004 Jan 01; 103(1):33-9. PubMed ID: 12969956
    [Abstract] [Full Text] [Related]

  • 12. [Chitotriosidase of human macrophages and mammalian chitinases: biological functions and abnormalities in pathology].
    Korolenko TA, Cherkanova MS.
    Vestn Ross Akad Med Nauk; 2009 Jan 01; (11):39-45. PubMed ID: 20017407
    [Abstract] [Full Text] [Related]

  • 13. Biomarkers in lysosomal storage diseases: a review.
    Cox TM.
    Acta Paediatr Suppl; 2005 Mar 01; 94(447):39-42; discussion 37-8. PubMed ID: 15895710
    [Abstract] [Full Text] [Related]

  • 14. [Comparison and clinical application of two methods for determination of plasma chitotriosidase activity].
    Wang Y, Zhang HW, Ye J, Qiu WJ, Han LS, Gu XF.
    Zhonghua Er Ke Za Zhi; 2012 Nov 01; 50(11):834-8. PubMed ID: 23302614
    [Abstract] [Full Text] [Related]

  • 15. Monitoring of Gaucher patients with a novel chitotriosidase assay.
    Schoonhoven A, Rudensky B, Elstein D, Zimran A, Hollak CE, Groener JE, Aerts JM.
    Clin Chim Acta; 2007 Jun 01; 381(2):136-9. PubMed ID: 17408605
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma chitotriosidase activity versus plasma glucosylsphingosine in wide spectrum of Gaucher disease phenotypes - A statistical insight.
    Tylki-Szymańska A, Szymańska-Rożek P, Hasiński P, Ługowska A.
    Mol Genet Metab; 2018 Apr 01; 123(4):495-500. PubMed ID: 29530534
    [Abstract] [Full Text] [Related]

  • 19. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.
    Dekker N, van Dussen L, Hollak CE, Overkleeft H, Scheij S, Ghauharali K, van Breemen MJ, Ferraz MJ, Groener JE, Maas M, Wijburg FA, Speijer D, Tylki-Szymanska A, Mistry PK, Boot RG, Aerts JM.
    Blood; 2011 Oct 20; 118(16):e118-27. PubMed ID: 21868580
    [Abstract] [Full Text] [Related]

  • 20. Modelling long-term evolution of chitotriosidase in non-neuronopathic Gaucher disease.
    Drugan C, Drugan TC, Grigorescu-Sido P, Naşcu I.
    Scand J Clin Lab Invest; 2017 Jul 20; 77(4):275-282. PubMed ID: 28319420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.